Dr. John Day - Myotonic Dystrophy Research: What's Next?
Stanford Medicine Myotonic Dystrophy Patient Meeting 2017 John W. Day, MD, PhD; Director, Neuromuscular Disorders Program; Professor of Neurology, Pediatrics & Pathology, Stanford Medicine Dr. Day has over 25 years of experience in diagnosing and treating those with neuromuscular diseases. He directs Stanford's pediatric and adult multi-disciplinary clinics andn is involved in research defining cause and treatments of neuromuscular disorders. Stanford is considered a "Center of Excellence" in myotonic dystrophy treatment and research.

▶︎
Dr. Carla Grosmann - Myotonic Dystrophy: An Overview

▶︎
DM1: Disease Development, Symptoms, & Management - 2021 MDF Annual Conference

▶︎
"The Future is Now: Neuroprotection & Vision Restoration for Glaucoma" - Jeffrey Goldberg, MD, PhD

▶︎
"Developments in Alzheimer’s Disease:From Diagnosis to Treatment" | 7 May2025

▶︎
Paramyotonia Congenita - An Expert Discussion | PPA SUMMIT 2021 Supercut #4

▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

▶︎
Updates on Deep Brain Stimulation, including adaptive DBS

▶︎
Extending Our Healthspan with Eric Topol, MD | 3 December 2025

▶︎
Treatment Options for Pain

▶︎
Stanford Cancer Institute Breakthroughs in Cancer: William Kaelin, Jr., MD

▶︎
A neuroscientist’s guide to protecting your brain, in 58 minutes | Lisa Genova: Full Interview

▶︎
Health Matters 2025: How Precision Medicine Is Changing the Future—and Your Health

▶︎
Stephen Meyer, John Lennox, and James Tour: Three Scientists on the Origins of Everything

▶︎
The most important lesson from 83,000 brain scans | Daniel Amen | TEDxOrangeCoast

▶︎
Sarah Stranberg - Dysphagia: Understanding Swallowing Issues in Myotonic Dystrophy

▶︎
Oxford Professor: AI Is Humanity’s Attempt to Make God — John Lennox

▶︎
Improve Energy & Longevity by Optimizing Mitochondria | Dr. Martin Picard

▶︎
Scientist Reveals How to BOOST NITRIC OXIDE to End Inflammation & REDUCE Blood Pressure

▶︎
The Challenges of Myotonic Dystrophy Type 1 by Martin E. Brown, MD Asst. Prof., UofL Neurology

▶︎
